Pay in 4 interest-free payments of $31.50 Learn more
Ships within 48 hours · Estimated delivery Sep 13 - Sep 18
which is currently under clinical trial for Alzheimer's disease
Smiles: OC(=O)CCCC(=O)NC1=CC=CC2=C1C(=O)N(C1CCC(=O)NC1=O)C2=O
It is of the reverse transcriptase inhibitor class
Formula: C16H14N2O2
Rapastinel Catalog No.:M13065-2 which is currently under clinicalRapastinel (GLYX 13) is an N methyl D aspartate receptor (NMDAR) modulator that has characteristics of a glycine site partial agonist. Target: NMDA Rapastinel is a robust cognitive enhancer and facilitates hippocampal long term potentiation (LTP) of synaptic transmission in slices. Product information CAS Number: 117928 94 6 Molecular Weight: 413. 47 Formula: C18H31N5O6 Synonym: GLYX 13 Chemical Name: (2S,3R) 2 {[(2S) 1 [(2S) 1 [(2S,3R) 2 amino 3